NCT03361527

Brief Summary

The goal of the study is to determine the benefit in speech intelligibility of the BBF and the MBF compared to an omni-directional microphone in different noise conditions. Secondary objective is to determine if there is a subjective preference for one of the microphone settings in different noise conditions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 23, 2015

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2016

Completed
1.1 years until next milestone

First Posted

Study publicly available on registry

December 5, 2017

Completed
Last Updated

August 23, 2024

Status Verified

August 1, 2024

Enrollment Period

1.2 years

First QC Date

November 23, 2015

Last Update Submit

August 21, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • speech reception thresholds (SRT) assessment with audiological measures (omni)

    The primary study outcome are speech reception thresholds (SRT) measured with omni-directional microphone setting

    10 months

  • speech reception thresholds (SRT) assessment with audiological measures (BBF)

    The primary study outcome are speech reception thresholds (SRT) measured with BBF microphone setting

    10 months

  • speech reception thresholds (SRT) assessment with audiological measures (MBF)

    The primary study outcome are speech reception thresholds (SRT) measured with MBF microphone setting

    10 months

Secondary Outcomes (3)

  • paired comparisons assessment with scaling (speech intelligibility)

    10 months

  • paired comparisons assessment with scaling (noise suppression)

    10 months

  • paired comparisons assessment with scaling (overall)

    10 months

Interventions

Each study participant will use an Advacned Bionics Naida CI Q90 loaner processor during the course of the study, an Advanced Bionics MyPilot remote control and- if applicable- a SmartPhone. the processors will be programmed with SoundWave and BEPSnet.

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

See below

You may qualify if:

  • all participants, which signed the Informed Consent (Appendix Informed Consent Form)
  • severe to profound hearing impairment - bilaterally implanted with either the CII or HiRes90k cochlear implant devices
  • experience with their more recent CI at least three months
  • usage of the Naida CI sound processor on each ear for at least three months
  • ability for speech understanding in the presence of competing noise without any assistance from lip-reading
  • score: at least 20% correct for a sentence test delivered with an SNR of +10 dB, or an SRT of better (lower) than +15 dB
  • ability to give subjective feedback in a certain listening situation
  • first language: German or Swiss-German
  • if participants are recruited additionally from other clinics, ability to travel to Zurich

You may not qualify if:

  • Acute inflammation or pain in head-/neck area
  • Dizziness
  • Age of participants \<18 years
  • Age of participants \> 80 years
  • Any participant who is found to require substantial changes to their standard clinical program may be either excluded, or be asked to first get used to the new program before returning for the study test session.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitätsspital Zürich, Klinik für ORL

Zurich, 8091, Switzerland

Location

Related Publications (7)

  • Buechner A, Dyballa KH, Hehrmann P, Fredelake S, Lenarz T. Advanced beamformers for cochlear implant users: acute measurement of speech perception in challenging listening conditions. PLoS One. 2014 Apr 22;9(4):e95542. doi: 10.1371/journal.pone.0095542. eCollection 2014.

  • Chung K, Zeng FG, Acker KN. Effects of directional microphone and adaptive multichannel noise reduction algorithm on cochlear implant performance. J Acoust Soc Am. 2006 Oct;120(4):2216-27. doi: 10.1121/1.2258500.

  • Chung K, Zeng FG. Using hearing aid adaptive directional microphones to enhance cochlear implant performance. Hear Res. 2009 Apr;250(1-2):27-37. doi: 10.1016/j.heares.2009.01.005. Epub 2009 Jan 22.

  • Chung K, Nelson L, Teske M. Noise reduction technologies implemented in head-worn preprocessors for improving cochlear implant performance in reverberant noise fields. Hear Res. 2012 Sep;291(1-2):41-51. doi: 10.1016/j.heares.2012.06.003. Epub 2012 Jun 28.

  • Compton-Conley CL, Neuman AC, Killion MC, Levitt H. Performance of directional microphones for hearing aids: real-world versus simulation. J Am Acad Audiol. 2004 Jun;15(6):440-55. doi: 10.3766/jaaa.15.6.5.

  • Kokkinakis K, Loizou PC. Multi-microphone adaptive noise reduction strategies for coordinated stimulation in bilateral cochlear implant devices. J Acoust Soc Am. 2010 May;127(5):3136-44. doi: 10.1121/1.3372727.

  • van der Beek FB, Soede W, Frijns JH. Evaluation of the benefit for cochlear implantees of two assistive directional microphone systems in an artificial diffuse noise situation. Ear Hear. 2007 Feb;28(1):99-110. doi: 10.1097/AUD.0b013e31802d0a55.

MeSH Terms

Conditions

Hearing Loss, Sensorineural

Condition Hierarchy (Ancestors)

Hearing LossHearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Norbert Dillier, Prof. Dr

    Universitätsspital Zürich, Klinik für ORL

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 23, 2015

First Posted

December 5, 2017

Study Start

September 1, 2015

Primary Completion

October 31, 2016

Study Completion

October 31, 2016

Last Updated

August 23, 2024

Record last verified: 2024-08

Locations